Details of the Drug Formulaction

General Information of Drug Formulation (ID: F19017)

• Formulation Name: Risedronic acid 150 mg tablet
• Company: Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Risedronate	(DM5FLTY)	Bone Paget disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
FD&C blue no. 2	(E00446)	2723854	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Mannitol	(E00103)	6251	Diluent; Flavoring agent; Lyophilization aid; Plasticizing agent; Tonicity agent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sunset yellow FCF	(E00255)	17730	Colorant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent